SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.26+1.2%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (7463)12/10/2002 2:38:09 PM
From: Sam Citron  Read Replies (1) of 52153
 
$150 for a proprietary webcast from Reed-Elsevir's PharmaNet? IMHO someone needs to bring a bit of "sunshine" into the entire FDA decision-making process. Providing free streaming audio of these ODAC meetings would be a step in the right direction. With these kinds of barriers to the dissemination of timely and highly material company-specific information, it is not surprising to me that the market for biotechs is highly "imperfect" (to use the EMH term) and that many astute individual investors like Jacob Snyder will stay away. In the aggregate, this causes distortions in the economy and misallocations of capital. I would imagine that a letter to the FDA commissioner advocating such changes and signed by the bright people on this thread might have the desired effect.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News